Stay updated on TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.

Latest updates to the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no user-facing study details or content appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedThe government funding status notice banner at the top of the page was removed.SummaryDifference0.3%

- Check41 days agoChange DetectedThe new page shows minor UI/layout adjustments to headings and formatting; there are no changes to core study data such as eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check69 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.SummaryDifference0.1%

Stay in the know with updates to TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.